학술논문

A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer
Document Type
Article
Source
In Clinical Lung Cancer May 2008 9(3):154-159
Subject
Original Contributions
Language
ISSN
1525-7304